Klotho is a novel therapeutic target in peritoneal fibrosis via Wnt signaling inhibition
- 28 March 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 35 (5), 773-781
- https://doi.org/10.1093/ndt/gfz298
Abstract
Background Long-term exposure to bioincompatible peritoneal dialysate causes the loss of mesothelial cells and accumulation of matrix proteins, leading to an increase in the thickness of the submesothelial layer, thereby limiting the long-term effectiveness of peritoneal dialysis (PD). However, the detailed molecular mechanisms underlying the process of peritoneal fibrosis have not been clearly elucidated. Wnt/β-catenin signaling pathway activation has been suggested to play a pivotal role in the development of organ fibrosis. Moreover, Klotho protein can regulate Wnt/β-catenin signaling. We examined the role of Klotho protein in reducing peritoneal fibrosis by inhibiting Wnt/β-catenin signaling. Methods The β-catenin-activated transgenic (BAT) driving expression of nuclear β-galactosidase reporter transgenic (BAT-LacZ) mice, the alpha-Klotho gene under control of human elongation factor 1 alpha promoter [Klotho transgenic (KLTG) and C57BL/6 background] and C57BL/6 mice [wild-type (WT)] were used. The mice received daily intraperitoneal (i.p.) injections of 4.25% glucose with lactate (PD solution) or saline as a control for 4 weeks. Other mice received daily i.p. injections of the same volume of saline (normal control). Results After exposure to PD, Wnt signal activation was observed on the peritoneal mesothelial cells in WT-PD mice. The peritoneal fibrosis was also accelerated in WT-PD mice. The protein expression of β-catenin and Wnt-inducible genes were also remarkably increased in WT-PD mice. On the other hand, KLTG-PD mice attenuated activation of Wnt/β-catenin signaling after exposure to PD and ameliorated the progression of peritoneal fibrosis. Conclusions Overexpression of Klotho protein protects the peritoneal membrane through attenuation of the Wnt/β-catenin signaling pathway. The availability of recombinant Klotho protein would provide a novel potential therapeutic target in peritoneal fibrosis.Funding Information
- Japan Society for the Promotion of Science (25461263)
- Research Project Grant
- Kawasaki Medical School
This publication has 30 references indexed in Scilit:
- New insights into the pathogenesis and treatment of peritoneal fibrosis: A potential role of Wnt/β-catenin induced epithelial to mesenchymal transition and stem cells for therapyMedical Hypotheses, 2013
- Canonical Wnt/β-catenin signaling mediates transforming growth factor-β1-driven podocyte injury and proteinuriaKidney International, 2011
- Inhibition of Wnt/β-catenin/CREB binding protein (CBP) signaling reverses pulmonary fibrosisProceedings of the National Academy of Sciences of the United States of America, 2010
- Biomarkers for epithelial-mesenchymal transitionsJCI Insight, 2009
- WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosisJCI Insight, 2009
- Cyclooxygenase-2 Mediates Dialysate-Induced Alterations of the Peritoneal MembraneJournal of the American Society of Nephrology, 2009
- β-Catenin Is a Mediator of the Response of Fibroblasts to IrradiationThe American Journal of Pathology, 2009
- Epithelial cell α3β1 integrin links β-catenin and Smad signaling to promote myofibroblast formation and pulmonary fibrosisJCI Insight, 2008
- Amelioration of progressive renal injury by genetic manipulation of Klotho geneProceedings of the National Academy of Sciences of the United States of America, 2007
- Suppression of Aging in Mice by the Hormone KlothoScience, 2005